Latest News- Generative AI In Personalized Medicine Market: Drug discovery is expected to lead the Application segment during 2025-2029

The Generative AI In Personalized Medicine Market is being driven by Accelerated drug discovery and development cycles as a primary catalyst

The Generative AI In Personalized Medicine Market is expected to grow at a CAGR of 41.1% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 8455.6 million. The generative AI in personalized medicine market represents a significant business transformation in the field, moving away from creating narrow, single-task AI models towards utilizing large-scale, pre-trained foundation models for biological data processing. This trend parallels the advancements in the broader AI sector, with large language models like GPT. However, these models are specifically tailored to address the intricacies of biological data. Trained on extensive, multimodal datasets consisting of petabytes of genomic, proteomic, transcriptomic, and chemical data, these foundation models learn the fundamental language and syntax of biological systems. Following an intensive training process, these models can be fine-tuned with smaller, more specialized datasets to execute a diverse range of downstream tasks, including protein function prediction, drug molecule design, and disease biomarker identification. 

Get more information on Generative AI In Personalized Medicine Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Application
  • Drug discovery
  • Disease diagnosis
  • Genomic analysis
• End-user
  • Pharmaceutical
  • Academic institutes
  • Hospitals
  • Diagnostic centers
• Therapeutic Area
  • Oncology
  • Neurology
  • Cardiology
  • Rare diseases
  • Infectious diseases
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • South Korea
  • South America
  • Middle East and Africa

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Accelerated drug discovery and development cycles as a primary catalyst
• Intensifying strategic collaborations and influx of capital as a key market accelerator
• Expansion of accessible multimodal data and computational power as a foundational enabler

However, the market also witnesses some limitations, which are as follows:

• Data scarcity, quality, and accessibility constraints
• Black Box problem and an evolving, uncertain regulatory landscape
• Prohibitive implementation costs and ambiguous reimbursement pathways

Benefits of Buying Global Generative AI In Personalized Medicine Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Generative AI In Personalized Medicine Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

In the realm of personalized medicine, Generative AI is revolutionizing various sectors. It is transforming drug discovery through platforms that leverage AI for biomarker discovery and drug efficacy modeling. Clinical workflows are automated, enabling personalized medicine platforms and patient engagement tools. AI-powered imaging analysis and ai-driven pathology enhance diagnostics in oncology, cardiology, and neurology. Patient data anonymization and genomic data security ensure data privacy. AI regulatory frameworks guide the development of precision medicine apps, digital therapeutics, and targeted therapies. Personalized vaccines and patient-specific treatments emerge with disease progression modeling and treatment optimization. Biomarker discovery, drug safety prediction, therapeutic response, and rare disease diagnostics also benefit from AI technology. AI in oncology, cardiology, neurology, and diagnostics are advancing patient care and improving clinical trial design.

Market Research Overview

In the dynamic landscape of the IT software industry, the application software segment, specifically within personalized medicine, is experiencing significant growth. This segment encompasses the development and production of AI-driven diagnostics, personalized drug design, genomic data integration, and patient stratification models. Leveraging machine learning algorithms, these solutions enable healthcare providers to deliver more precise and effective treatments. The global application software market for personalized medicine is a subset of the larger IT software market, which includes companies providing all types of software, including cloud-based solutions. Technavio's market analysis calculates the market size based on the combined revenue generated by these companies.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/